Genomic surveillance reveals that the dengue 2 virus lineage responsible for the 2023-2024 epidemic in the French Caribbean Islands is resistant to Mosnodenvir
Bouzidi, H. S.; Sen, S.; Piorkowski, G.; Pezzi, L.; Ayhan, N.; Fontaine, A.; Canivez, T.; Geulen, M.; Amaral, R.; Grard, G.; Durand, G. A.; de Lamballerie, X.; Touret, F.; Klitting, R.
Show abstract
Dengue fever is the most important arbovirosis for public health, with more than 5 million cases worldwide in 2023. Mosnodenvir is the first anti-dengue compound with very high preclinical pan-serotype activity, currently undergoing phase 2 clinical evaluation. Here, by analyzing dengue virus (DENV) genomes from the ongoing epidemic in the French Caribbean Islands, we show that they all exhibit mutation NS4B:V91A, previously associated with strong resistance to mosnodenvir in vitro. Using antiviral activity tests on clinical and reverse-genetic strains, we confirm a 600-fold decrease in mosnodenvir sensitivity. Finally, combining phylogenetic analysis and experimental testing for resistance, we find that the V91A resistance mutation likely emerged multiple times over the last 30 years in DENV-2 and DENV-3. These results call for increased genomic surveillance, in particular to track lineages with resistance mutations. These efforts should allow to better assess the activity profile of DENV treatments in development against circulating strains.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Major change in swine influenza virus diversity in France owing to emergence and widespread dissemination of a newly introduced H1N2 1C genotype in 2020 94%
- Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants 94%
- Multiple introductions and country-wide spread of DENV-2 genotype II (Cosmopolitan) in Brazil 94%
Similar papers in this journal
- Highly pathogenic avian influenza A (H5N1) in marine mammals and seabirds in Peru 96%
- Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections 95%
- The association of neutralizing antibodies with protection against symptomatic dengue virus infection varies by serotype, prior infection history, and assay condition 95%
Similar papers in this journal
- The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Black Queen rule 95%
- Culture and identification of a “Deltamicron” SARS-CoV-2 in a three cases cluster in southern France 95%
- Infectious subgenomic amplicon strategies for Japanese encephalitis and West Nile viruses 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.